Eurofins Scientific SE
ERF
Κατάταξη σε μετοχές
#1379
Eurofins Scientific SE, together with its subsidiaries, provides various... Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. It provides services, such as agroscience, including biological assessment, consumer and human, environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, including sustainability, audit, certification, quality inspection, QA-QC programme, and food and dietary supplement labelling services; biopharma, and clinical diagnostics. The company also offers consumer product testing, which include sustainability, testing, certifications and approvals, expert services and regulatory, inspections, audits, consumer research and sensory evaluation, and training courses; cosmetics and personal care; and electrical and electronics laboratories services. In addition, it provides environment testing, including maritime, water, air, soil, building material, pollution, waste, fuel/oil, microplastics, and radioactivity testing; and food and feed testing that include allergen, audit and certification, authenticity, carbohydrates, consulting, dioxins and POPs, food irradiation, GMO, heavy metal, melamine, microbiology, molecular biology, mycotoxin, nutritional analyses, organic contaminants, pesticide, veterinary drug, vitamin, and residual DNA testing. Further, the company provides forensic, genomic, maritime, materials and engineering, REACH, and sensory and consumer services, as well as in vitro diagnostics and PSS insourcing solutions. The company was founded in 1987 and is headquartered in Luxembourg, Luxembourg.
Τιμή μετοχής
$93.33
Τελευταίος συγχρονισμός: 2026-10-20
Κεφαλαιοποίηση
$16.20B
Αλλαγή (1 ημέρα)
-0.33%
Αλλαγή (1 έτος)
28.73%
Χώρα
LU
Εμπόριο Eurofins Scientific SE (ERF)
Κατηγορία
Healthcare
Κέρδη για την Eurofins Scientific SE (ERF)
Κέρδη τον Jun 2026 TTM: $862.10M
Σύμφωνα με τις τελευταίες οικονομικές αναφορές της Eurofins Scientific SE, τα τρέχοντα κέρδη της εταιρείας είναι $862.10M. Το 2024, η εταιρεία παρουσίασε κέρδη $577.10M, αύξηση σε σχέση με των κερδών του 2023 που ήταν $467.94M. Τα κέρδη που εμφανίζονται σε αυτή τη σελίδα είναι πριν από τόκους και φόρους, γνωστά και ως EBIT.
Ιστορικό κερδών για την Eurofins Scientific SE από 2002 έως 2026
Κέρδη στο τέλος κάθε έτους
| Έτος | Κέρδη | Αλλαγή |
|---|---|---|
| 2026 (TTM) | $862.10M | 12.35% |
| 2025 | $767.32M | 32.96% |
| 2024 | $577.10M | 23.33% |
| 2023 | $467.94M | -44.07% |
| 2022 | $836.69M | -30.36% |
| 2021 | $1.20B | 42.07% |
| 2020 | $845.69M | 177.62% |
| 2019 | $304.62M | -8.54% |
| 2018 | $333.07M | 10.99% |
| 2017 | $300.10M | 17.56% |
| 2016 | $255.27M | 77.62% |
| 2015 | $143.72M | 17.22% |
| 2014 | $122.61M | 0.11% |
| 2013 | $122.48M | 13.68% |
| 2012 | $107.74M | 18.11% |
| 2011 | $91.22M | 88.59% |
| 2010 | $48.37M | -1,720.16% |
| 2009 | $-2.99M | -107.78% |
| 2008 | $38.37M | -9.89% |
| 2007 | $42.58M | 4.56% |
| 2006 | $40.72M | 46.24% |
| 2005 | $27.85M | 72.80% |
| 2004 | $16.11M | 196.15% |
| 2003 | $5.44M | 145.28% |
| 2002 | $2.22M | 0.00% |
Κέρδη παρόμοιων εταιρειών ή ανταγωνιστών
| Εταιρεία | Κέρδη | Διαφορά Κερδών | Χώρα |
|---|---|---|---|
| $7.61B | 782.61% |
US
|
|
| $4.76B | 452.37% |
US
|
|
| $-252.70M | -129.31% |
US
|
|
| - | - |
CN
|
|
| $1.66B | 92.32% |
US
|
